Your session is about to expire
← Back to Search
Diagnostic (contrast agent, CEUS) for Breast Cancer
Study Summary
This trial explores using ultrasound to determine if a breast mass is benign or malignant without using radiation. Results could help determine if a biopsy is needed.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Does this clinical trial have any vacancies?
"According to the records hosted on clinicaltrials.gov, this medical study is actively seeking volunteers. It was initially posted on November 5th 2020 and its most recent update occurred December 5th 2023."
How many participants is this clinical trial accommodating?
"Affirmative. The information accessible on clinicaltrials.gov confirms that this investigation is recruiting participants; it was first announced on November 5th 2020 and has been updated as recent as December 5th 2023. This experiment aims to find 100 suitable candidates from two separate sites."
Is CEUS a reliable and safe diagnostic tool?
"There is limited evidence to support the safety and efficacy of Diagnostic (contrast agent, CEUS) so it was given a value of 1."
Share this study with friends
Copy Link
Messenger